Although the interaction among glucocorticoids and cytokines is often cell type specific and depends on the physiologic context of the cell, our data point towards the NF-κB system as a potential therapeutic target in the combat against some hormone-dependent forms of mammary cancer. Here, NFKB1 is linked to breast cancer.